PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
about
sameAs
Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and functionSerine racemase binds to PICK1: potential relevance to schizophreniaFunctional consequences of PRODH missense mutationsPolymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophreniaBipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent triosConverging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndromeA Conserved Active Site Tyrosine Residue of Proline Dehydrogenase Helps Enforce the Preference for Proline over Hydroxyproline as the Substrate † ‡Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit developmentAssociation study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysisStructures of the Escherichia coli PutA proline dehydrogenase domain in complex with competitive inhibitorsHyperprolinemia is a risk factor for schizoaffective disorderEvidence that the gene encoding ZDHHC8 contributes to the risk of schizophreniaSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceUnraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.Cytosolic Accumulation of L-Proline Disrupts GABA-Ergic Transmission through GAD BlockadeEvidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcomeThe 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.Contribution of nonprimate animal models in understanding the etiology of schizophrenia.22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia.Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.Velo-Cardio-Facial Syndrome.Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypesSlgA, encoded by the homolog of the human schizophrenia-associated gene PRODH, acts in clock neurons to regulate Drosophila aggressionFinding schizophrenia genes.Proline suppresses apoptosis in the fungal pathogen Colletotrichum trifolii.Supportive evidence for reduced expression of GNB1L in schizophrenia.Proton magnetic resonance spectroscopy in 22q11 deletion syndrome.22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis.Schizophrenia: neural mechanisms for novel therapiesThe genetics of schizophrenia and bipolar disorder: dissecting psychosisMolecular characterization of deletion breakpoints in adults with 22q11 deletion syndromeDetection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformationsPharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome.Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stressGlutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.Chromosomal phenotypes and submicroscopic abnormalitiesIntegrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletionPharmacogenomics: a path to predictive medicine for schizophrenia.Translational research in central nervous system drug discovery.
P2860
Q21145031-DE214CF9-8B8D-49AB-9EB1-862F11D5BA1BQ24297355-4D65EE97-296A-43FD-A4A4-61AB7A59987EQ24338650-1ECF8FB0-D13D-4AE6-A969-541EB855FB15Q24533619-6D359416-635F-40F9-9AFF-6BA189316101Q24538580-E1B14B1F-7337-48F2-853F-1E6A8FF02438Q26824150-5BB1E58E-AFBD-44BB-AECD-6A4D9ED0826CQ27653411-ECF7B5B0-9CFB-44B7-AC60-F0214B2B1034Q28081179-C12F3880-D8AB-49BD-9815-858F29069C9AQ28247655-8F62EE59-4B1C-4A1F-91F0-B5D9D29D3B2AQ28284796-64635886-D328-4D11-9A1A-C6BD3CBBA1A2Q28288735-894C639D-0061-4457-A28D-C510906CE960Q28591536-86EEA06D-5C55-45AE-8299-883969E15FACQ29618819-3EF4A7FD-7402-4B45-BF93-81F5228CEC7DQ30241067-94B20F76-C3A9-48EF-97DC-0D5AF1553FE1Q30370117-C5F03785-127E-4651-ABFF-B267846715BAQ30464317-46940651-E0BF-4DAF-9711-39911CF7CF9EQ30468033-4463D29D-B5A3-47D3-9DB3-4DF0E6B40D46Q30474963-0D895102-A5F2-42DA-8479-9FD49A527112Q30478713-59D29597-F813-41D7-8FE8-6C68D9A4BBD7Q30480908-57D89F4F-E0DD-4A90-AD40-388C48B2EEFEQ31108616-77A44743-33E9-4DE0-AE14-98CACAAB9253Q33612908-798FB6BA-AD60-4BF4-932E-995C81B65E36Q33729433-C0096E85-5A8C-4AB6-91C4-24B17292BC1BQ33830480-C1ED6C1F-BAD9-43AD-90EC-58AB9B8F87A5Q33831956-1E9F6325-B65E-44F6-9B84-30E1070ED2BCQ33927328-B37FC1AA-AFBF-47A0-BDD6-54E836AD05FBQ33950938-BA3FB4D1-FDC5-42C3-8170-7DA513DD2DF1Q33955280-48E1D0A4-B6AD-4D70-9F36-CDB03877881DQ34393037-6AA49CE9-8C71-4084-8D97-669BF8BEBD1DQ34520335-11C16335-6D78-4662-99BC-BBAE20C22EFFQ34555635-FD36616B-A241-4784-A155-3286AAEC9F2DQ35115385-90303319-3306-4223-BB0B-550FC0F427ACQ35447657-112B19E9-C08C-4434-BFD2-722D1C287C14Q35805941-1EB78644-0CC6-4B73-8A27-01EBBD437CE8Q35955745-9C05A751-9002-4AD3-BC35-F974B2DAACBDQ35956869-6DE3BDE8-5226-4089-8536-A944D6603AD5Q35985485-97B0AED0-6A13-4BD8-8008-52D86FA8FF5AQ36193399-CE778CA9-48EA-415B-95F8-A4F2A7B61C84Q36341739-51B2AA77-872E-4CD1-93ED-E42783827BD2Q36401418-1C4FBC81-B770-4059-900A-460A30E1954C
P2860
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@ast
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@en
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@nl
type
label
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@ast
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@en
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@nl
prefLabel
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@ast
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@en
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@nl
P2093
P3181
P356
P1476
PRODH mutations and hyperprolinemia in a subset of schizophrenic patients
@en
P2093
Bernadette Hecketsweiler
Caroline Demilly
Emmanuelle Houy
Florence Thibaut
Gabrielle Allio
Gael Fouldrin
Grégory Raux
Hélène Jacquet
Jacqueline Bou
Michel Petit
P304
P3181
P356
10.1093/HMG/11.19.2243
P407
P577
2002-09-15T00:00:00Z